- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 11, 2025 | 21.87M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 14.2M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 8.99M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 2.65M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 2.37M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $0 |
| Capex | Q3 2025 · Sep 30, 2024 | $0 |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$43.41M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$57.22M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $92.3M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $102.51M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $16.82M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $36.18M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $29.85M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $40.39M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$88.92M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$107.67M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$90.17M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$93.1M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$85.63M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$74.3M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$72.36M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$56.51M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $37.8M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $22.23M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $133.71M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $131.44M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $44.4M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $37.39M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $44.79M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $38.34M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.18 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$6.38 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$5.15 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$20.60 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.18 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$6.38 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$5.15 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$20.60 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $5.38M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $16.69M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $7.68M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $30.4M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $8.74M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $23.55M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $5.1M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $24.53M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$30.91M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$57.35M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$19.19M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$7.25M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$13.65M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$48.74M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$8.3M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$26.79M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$14.23M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$40.18M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$15.29M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$56.75M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $11K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $132K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.17M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.31M |
| Revenue | Q3 2025 · Sep 30, 2025 | $98K |
| Revenue | Q3 2025 · Sep 30, 2025 | $386K |
| Revenue | Q3 2025 · Sep 30, 2024 | $214K |
| Revenue | Q3 2025 · Sep 30, 2024 | $1.9M |